EREG is a known ligand for the epidermal growth factor receptor (EGFR), and its overexpression has been implicated in promoting proliferation in various cancers (Chen et al., 2022; Gonzalez-Conchas et al., 2018). This evidence concerns the gene EGFR and cancer.